Hemoglobinopathy Testing Strategies [Archived Webinar]

Expires: January 17, 2020

Many diagnosticians consider hemoglobin disorders in the context of microcytosis or sickling syndromes. However, other symptoms associated with hemoglobinopathies may not be as well-known. Even if a hemoglobin disorder is considered, incomplete information can lead to a missed or delayed diagnosis and/or unnecessary testing. The diagnosis of hemoglobinopathies and thalassemias employs many platforms with complementary strengths and weaknesses, and interpretation can be complex. This webinar will discuss the strategy of hemoglobin testing profiles to address these issues. We will review the methods used and present cases to illustrate the utility of algorithms used at Mayo Clinic.

View the Archived Webinar

Already registered? Sign in here.

Presenter

Jennifer Oliveira, M.D.
Consultant, Division of Hematopathology
Assistant Professor of Laboratory Medicine and Pathology
Mayo Clinic, Rochester, Minnesota

 

 

Learning Objectives

  • Review symptoms of hemoglobin disorders beyond microcytosis and sickling syndromes.
  • Describe testing methods within profiles that are used to diagnose hemoglobin disorders, including protein and molecular assays.
  • Discuss clinical cases that illustrate the utility of hemoglobin profile-testing strategies at Mayo Clinic.

 

Intended Audience

This webinar is designed for health care professionals who treat patients with hemoglobinopathies, including hematopathologists, hematologists, physician assistants, nurse practitioners, and genetic counselors.

 

Credit

The following types of credit are offered for this event:
ASCLS P.A.C.E.®
State of California
State of Florida

To obtain credit:

  1. Watch the video.
  2. Complete the posttest and evaluation that launches immediately following the video.
  3. Generate and print your certificate(s).

 

ASCLS P.A.C.E.®

Mayo Medical Laboratories is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This program has been approved for a maximum of 1.0 P.A.C.E® contact hour. Level of instruction for this program is intermediate.

State of California

Mayo Medical Laboratories is approved as a Continuing Education Accrediting Agency for Clinical Laboratory Sciences for State of California credit. The level of instruction for this program is intermediate. This program has been approved for 1.0 contact hour.

State of Florida

Mayo Medical Laboratories is approved as a Continuing Education Accrediting Agency for Clinical Laboratory Sciences for State of Florida credit. Florida Board of Clinical Laboratory Personnel has designated this program for Hematology credit. The level of instruction for this program is intermediate. This program has been approved for 1.0 contact hour.

Faculty Disclosure

Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.

National Physician Payment Transparency Program

Mayo Medical Laboratories is not an applicable manufacturer or applicable group purchasing organization (GPO). (GPOs, per the Centers for Medicare & Medicaid Services, and this program do not trigger any reporting requirements pursuant to Open Payments [Sunshine Act] legislation.)

mmledu

MML Education

This post was developed by our Education and Technical Publications Team.